MIRA INFORM REPORT
|
Report No. : |
312259 |
|
Report Date : |
24.04.2015 |
IDENTIFICATION DETAILS
|
Name : |
NAVA SANJIVANI DRUGS |
|
|
|
|
|
|
Registered
Office : |
D No. 6-3-647/9, Shop No. 1A and 1B,
Riviera Apartments, Dwarakapuri Colony, Panjagutta, Hyderabad –
500082, Telangana |
|
|
Tel. No.: |
91-40-64514567 |
|
|
|
|
|
|
Country : |
India |
|
|
|
|
|
|
Financials (as
on) : |
31.03.2015 (Provisional) |
|
|
|
|
|
|
Year of
Establishment : |
2010 |
|
|
|
|
|
|
Capital
Investment : |
Rs. 16.959 Million |
|
|
|
|
|
|
PAN No.: [Permanent Account No.] |
Not Available |
|
|
|
|
|
|
Legal Form : |
Partnership Concern with an Unlimited Liability of the Partners |
|
|
|
|
|
|
Line of Business
: |
Trader of Medicines like Anti-Cancer, Nephrology, Virology, etc. |
|
|
|
|
|
|
No. of Employees
: |
10 (Approximately) |
|
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (48) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established partnership concern engaged in the business
as a trader of medicines having satisfactory track record. The concern is progressing well. General financial position of the
concern is decent. Trade relations are reported as fair. Business is active. Payment
terms are reported to be usually correct and as per commitments. The concern can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EXTERNAL AGENCY RATING
NOT AVAILABLE
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2014.
INFORMATION PARTED BY
|
Name : |
Mr. Soothram Venkata Subrahmanyam |
|
Designation : |
Partner |
|
Contact No.: |
91-9849021073 |
|
Date : |
22.04.2015 |
LOCATIONS
|
Registered Office : |
D No. 6-3-647/9, Shop No. 1A and 1B,
Riviera Apartments, Dwarakapuri Colony, Panjagutta, Hyderabad –
500082, Telangana, India |
|
Tel. No.: |
91-40-64514567 |
|
Mobile No.: |
91-9849021073 [Mr. Soothram Venkata Subrahmanyam] |
|
Fax No.: |
Not Available |
|
E-Mail : |
PARTNERS
|
Name : |
Mr. Soothram Venkata Subrahmanyam |
|
Designation : |
Partner |
|
Address : |
Door No. 30-240/2, Plot No. 44, Dwarakamayee Colony, Old Safilguda,
Secunderabad – 500056, Telangana, India |
|
Date of Birth/Age : |
24.05.1969 |
|
PAN No.: |
AWXPS1201L |
|
|
|
|
Name : |
Mrs. Sarala Soothram |
|
Designation : |
Partner |
|
Address : |
Door No. 30-240/2, Plot No. 44, Dwarakamayee Colony, Old Safilguda,
Secunderabad – 500056, Telangana, India |
|
Date of Birth/Age : |
02.03.1975 |
|
PAN No.: |
CXXPS9246Q |
|
|
|
|
Name : |
Mr. Anil Kumar Kandi |
|
Designation : |
Partner |
|
Address : |
1-8-32/27, Bapubagh Colony, P.G. Road, Secunderabad – 500003, Telangana, India |
|
Date of Birth/Age : |
17.09.1972 |
|
PAN No.: |
AIUPK3859R |
|
|
|
|
Name : |
Mr. Arvind Kumar Kandi |
|
Designation : |
Partner |
|
Address : |
1-8-32/27, Bapubagh Colony, P.G. Road, Secunderabad – 500003, Telangana, India |
|
Date of Birth/Age : |
22.03.1976 |
|
PAN No.: |
AHYPK5007G |
|
|
|
|
Name : |
Mr. Naveen Kumar Poddaturi |
|
Designation : |
Partner |
|
Address : |
Plot No. 18 and 19, Tirumala Enclave, Karkhana, Secunderabad – 500015,
Telangana,
India |
|
Date of Birth/Age : |
30.03.1972 |
|
PAN No.: |
AFEPP5650A |
BUSINESS DETAILS
|
Line of Business : |
Trader of Medicines like Anti-Cancer, Nephrology, Virology, etc. |
|
|
|
|
Brand Names : |
-- |
|
|
|
|
Agencies Held : |
-- |
|
|
|
|
Exports : |
|
|
Products : |
-- |
|
Countries : |
-- |
|
|
|
|
Imports : |
|
|
Products : |
-- |
|
Countries : |
-- |
|
|
|
|
Terms : |
|
|
Selling : |
Cash and Credit |
|
|
|
|
Purchasing : |
Cash and Credit |
GENERAL INFORMATION
|
Suppliers : |
· Roche Diagnostics India Private Limited Address: Hisaria WH,
Ground and First Floor, Block D, Survey No. 218/1 A1, 219/1A1A, 219/1A1,
Madhavaram Red Hills High Road, Vadeperambakkam, Puzhal Village, Thiruvallur
District Chennai – 600060, Tamilnadu, India Contact Person: Mr. Jacob Contact No.: 91-8790001010 · Novartis India Private Limited Address: Survey No. 24, 25, 26, Ground Floor, Hyderabad – 501359, Telangana, India Contact Person: Mr. Ratan Contact No.: 91-8106654563 |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
Retailers and End Users
· Basavatarakam Indo-American Cancer Hospital Address: Banjara Hills,
Hyderabad, Telangana, India Contact Person: Mr. Hussain Contact No.: 91-9912225341 · Krishna Institute of Medical Sciences Address: Secunderabad, Telangana, India Contact Person: Mr. Murali Contact No.: 91-9059926066 |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
10 (Approximately) |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
· Yes Bank Limited · ICICI Bank Limited · Standard Chartered Bank |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Auditors : |
|
|
Name : |
N. Dayakar and Company Chartered Accountants |
|
|
|
|
Associates/Subsidiaries : |
Not Available |
CAPITAL STRUCTURE
PARTNERS CAPITAL AS ON 31.03.2015
[PROVISIONAL]
|
PARTICULARS |
AMOUNT IN
MILLION |
|
|
|
|
K. Anil Kumar |
2.567 |
|
S. V. Subrahmanyam |
3.748 |
|
P. Naveen Kumar |
1.144 |
|
S. Sarala |
5.423 |
|
K. Arvind Kumar |
4.077 |
|
|
|
|
Total |
16.959 |
FINANCIAL DATA
[all figures are in
Rupees Million]
Note : Sole Proprietary and Partnership concerns are
exempted from filing their financials with the Government Authorities or
Registry.
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2015 [Provisional] |
31.03.2014 |
31.03.2013 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Partners Capital |
16.959 |
16.696 |
12.538 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Profit and Loss Account |
0.000 |
0.000 |
0.000 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
16.959 |
16.696 |
12.538 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
1.256 |
1.800 |
0.000 |
|
|
2] Unsecured Loans |
24.913 |
23.273 |
10.868 |
|
|
TOTAL BORROWING |
26.169 |
25.073 |
10.868 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
43.128 |
41.769 |
23.406 |
|
|
|
|
|
|
|
|
APPLICATION OF
FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
2.751 |
3.144 |
1.049 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.863 |
0.825 |
0.000 |
|
|
DEFERRED TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
23.074
|
17.884 |
11.629 |
|
|
Sundry Debtors |
27.170
|
37.054 |
18.406 |
|
|
Cash & Bank Balances |
(0.145)
|
(0.094) |
5.359 |
|
|
Other Current Assets [Deposits] |
0.852
|
1.320 |
1.275 |
|
|
Loans & Advances |
1.556
|
0.216 |
0.000 |
|
Total
Current Assets |
52.507
|
56.380 |
36.669 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
12.831
|
18.149 |
13.687 |
|
|
Other Current Liabilities |
0.000
|
0.000 |
0.000 |
|
|
Provisions |
0.162
|
0.431 |
0.625 |
|
Total
Current Liabilities |
12.993
|
18.580 |
14.312 |
|
|
Net Current Assets |
39.514
|
37.800 |
22.357 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
43.128 |
41.769 |
23.406 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2015 [Provisional] |
31.03.2014 |
31.03.2013 |
|
|
|
SALES |
|
|
|
|
|
|
|
Sales |
154.841 |
136.447 |
119.971 |
|
|
|
Other Income |
1.538 |
0.905 |
0.331 |
|
|
|
TOTAL |
156.379 |
137.352 |
120.302 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Goods sold |
142.928 |
123.820 |
108.657 |
|
|
|
CST |
0.000 |
0.142 |
0.312 |
|
|
|
Salaries |
3.052 |
3.561 |
3.097 |
|
|
|
Rent |
0.169 |
0.167 |
0.139 |
|
|
|
Electricity Charges |
0.130 |
0.128 |
0.098 |
|
|
|
Bank Charges and Processing Fees |
0.091 |
0.445 |
0.606 |
|
|
|
Repairs and Maintenance |
0.090 |
0.056 |
0.112 |
|
|
|
Petrol and Diesel Expenses |
0.166 |
0.161 |
0.609 |
|
|
|
Institution Support Expenses |
0.498 |
0.011 |
0.207 |
|
|
|
Patient Support Expenses |
0.534 |
0.052 |
0.214 |
|
|
|
Marketing Support Expenses |
0.865 |
0.241 |
0.000 |
|
|
|
Interest on Secured Loans |
0.155 |
0.000 |
0.000 |
|
|
|
Interest on Unsecured Loans |
2.379 |
2.034 |
1.271 |
|
|
|
Interest on Capital |
1.728 |
1.673 |
1.217 |
|
|
|
Partners Salaries |
1.600 |
1.420 |
1.100 |
|
|
|
Other Expenses |
0.490 |
2.308 |
1.899 |
|
|
|
TOTAL |
154.875 |
136.219 |
119.538 |
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE DEPRECIATION AND AMORTISATION |
1.504 |
1.133 |
0.764 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/ AMORTISATION |
0.501 |
0.307 |
0.163 |
|
|
|
|
|
|
|
|
|
|
NET PROFIT |
1.003 |
0.826 |
0.601 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2015 [Provisional] |
31.03.2014 |
31.03.2013 |
|
Net Profit Margin (PAT/Sales) |
(%) |
0.65
|
0.61 |
0.50 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
1.82
|
1.39 |
1.59 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.06
|
0.05 |
0.05 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
1.54
|
1.50 |
0.87 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
4.04
|
3.03 |
2.56 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Million]
DEBT EQUITY RATIO
|
Particulars |
31.03.2013 |
31.03.2014 |
31.03.2015
[Provisional] |
|
|
(Rs.
In Million) |
(Rs.
In Million) |
(Rs.
In Million) |
|
Share Capital |
12.538 |
16.696 |
16.959 |
|
Reserves & Surplus |
0.000 |
0.000 |
0.000 |
|
Net
worth |
12.538 |
16.696 |
16.959 |
|
|
|
|
|
|
Long-term borrowings |
0.000 |
1.800 |
1.256 |
|
Short term borrowings |
10.868 |
23.273 |
24.913 |
|
Total
borrowings |
10.868 |
25.073 |
26.169 |
|
Debt/Equity
ratio |
0.867 |
1.502 |
1.543 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2013 |
31.03.2014 |
31.03.2015
[Provisional] |
|
|
(Rs.
In Million) |
(Rs.
In Million) |
(Rs.
In Million) |
|
Sales |
119.971 |
136.447 |
154.841 |
|
|
|
13.733 |
13.481 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2013 |
31.03.2014 |
31.03.2015
[Provisional] |
|
|
(Rs.
In Million) |
(Rs.
In Million) |
(Rs.
In Million) |
|
Sales |
119.971 |
136.447 |
154.841 |
|
Profit |
0.601 |
0.826 |
1.003 |
|
|
0.50% |
0.61% |
0.65% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact
person |
Yes |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
-- |
|
14] |
Estimation for coming
financial year |
Yes |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
No |
|
17] |
Major suppliers |
Yes |
|
18] |
Major customers |
Yes |
|
19] |
Payments terms |
Yes |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm
/ promoter involved in |
-- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
Yes |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
No |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
No |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
Yes |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating,
if available |
No |
------------------------------------------------------------------------------------------------------------------------------
UNSECURED LOANS
(RS. IN MILLION)
|
PARTICULARS |
31.03.2015 (Provisional) |
31.03.2014 |
|
|
|
|
|
Unsecured Loans |
24.913 |
23.273 |
|
|
|
|
|
Total |
24.913 |
23.273 |
------------------------------------------------------------------------------------------------------------------------------
NAVA SANJIVANI DRUGS
BALANCE SHEET
(RS. IN MILLION)
|
SOURCES OF FUNDS |
|
31.03.2016 [Projected] |
31.03.2017 [Projected] |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Partners Capital |
|
21.040 |
26.320 |
|
|
2] Share Application Money |
|
0.000 |
0.000 |
|
|
3] Profit and Loss Account |
|
0.000 |
0.000 |
|
|
4] (Accumulated Losses) |
|
0.000 |
0.000 |
|
|
NETWORTH |
|
21.040 |
26.320 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
0.800 |
0.600 |
|
|
2] Unsecured Loans |
|
17.000 |
16.000 |
|
|
TOTAL BORROWING |
|
17.800 |
16.600 |
|
|
DEFERRED TAX LIABILITIES |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
38.840 |
42.920 |
|
|
|
|
|
|
|
|
APPLICATION OF
FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
2.421 |
2.018 |
|
|
Capital work-in-progress |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
0.700 |
0.600 |
|
|
DEFERRED TAX ASSETS |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
22.500 |
27.500 |
|
|
Sundry Debtors |
|
28.000 |
30.000 |
|
|
Cash & Bank Balances |
|
0.519 |
0.227 |
|
|
Other Current Assets [Deposits] |
|
0.900 |
1.000 |
|
|
Loans & Advances |
|
1.400 |
1.750 |
|
Total
Current Assets |
|
53.319 |
60.477 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
|
17.500 |
20.000 |
|
|
Other Current Liabilities |
|
0.000 |
0.000 |
|
|
Provisions |
|
0.100 |
0.175 |
|
Total
Current Liabilities |
|
17.600 |
20.175 |
|
|
Net Current Assets |
|
35.719 |
40.302 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
38.840 |
42.920 |
|
------------------------------------------------------------------------------------------------------------------------------
NAVA SANJIVANI DRUGS
PROFIT & LOSS ACCOUNT
(RS. IN MILLION)
|
|
PARTICULARS |
|
31.03.2016 [Projected] |
31.03.2017 [Projected] |
|
|
|
SALES |
|
|
|
|
|
|
|
Sales |
|
175.000 |
200.000 |
|
|
|
Other Income |
|
1.615 |
1.725 |
|
|
|
TOTAL |
|
176.615 |
201.725 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Goods sold |
|
161.574 |
185.000 |
|
|
|
Salaries |
|
3.500 |
4.000 |
|
|
|
Rent |
|
0.195 |
0.225 |
|
|
|
Electricity Charges |
|
0.135 |
0.150 |
|
|
|
Bank Charges and Processing Fees |
|
0.096 |
0.110 |
|
|
|
Repairs and Maintenance |
|
0.090 |
0.125 |
|
|
|
Petrol and Diesel Expenses |
|
0.175 |
0.200 |
|
|
|
Institution Support Expenses |
|
0.600 |
0.700 |
|
|
|
Patient Support Expenses |
|
0.550 |
0.600 |
|
|
|
Marketing Support Expenses |
|
0.850 |
0.900 |
|
|
|
Interest on Secured Loans |
|
0.130 |
0.090 |
|
|
|
Interest on Unsecured Loans |
|
2.450 |
2.000 |
|
|
|
Interest on Capital |
|
2.035 |
2.520 |
|
|
|
Partners Salaries |
|
2.000 |
2.500 |
|
|
|
Other Expenses |
|
0.575 |
0.755 |
|
|
|
TOTAL |
|
174.955 |
199.875 |
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE DEPRECIATION AND AMORTISATION |
|
1.660 |
1.850 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
|
0.450 |
0.400 |
|
|
|
|
|
|
|
|
|
|
NET PROFIT |
|
1.210 |
1.450 |
|
------------------------------------------------------------------------------------------------------------------------------
NETWORTH STATEMENT
MR. SOOTHRAM VENKATA
SUBRAHMANYAM
(RS. IN MILLION)
|
LIABILITIES |
31.03.2015 |
ASSETS |
31.03.2015 |
|
|
|
|
|
|
Home Loan / Mortgage Loan |
2.500 |
Immovable Properties Residential House bearing No. 30-240/2, Plot
No. 44, Dwarakamai Colony, Old Safilguda, Secunderabad, admeasuring 200 Sq.
Yds. |
7.500 |
|
|
|
|
|
|
Personal Loan / LIC Loan |
0.000 |
Investments in Shares/ Securities |
0.000 |
|
Car Loan |
0.000 |
Gold/ Jewellery |
0.300 |
|
Any Other Loan/ Liabilities |
0.000 |
Car |
0.000 |
|
|
|
Fixed Deposit / LIC etc. |
0.900 |
|
|
|
Cash in hand |
0.030 |
|
|
|
|
|
|
|
|
Other Investments Capital in Partnership Firm (20% Share) Nava
Sanjivani Drugs 6-3-347/9, Shop No. 1, Dwarkapuri Colony, Punjagutta,
Hyderabad |
3.750 |
|
|
|
|
|
|
|
|
|
|
|
TOTAL [A] |
2.500 |
TOTAL [B] |
12.480 |
|
NETWORTH [Rs. 12.480 Million – Rs. 2.500 Million] |
RS.
9.980 MILLION |
------------------------------------------------------------------------------------------------------------------------------
NETWORTH STATEMENT
MRS. SARALA SOOTHRAM
(RS. IN MILLION)
|
LIABILITIES |
31.03.2015 |
ASSETS |
31.03.2015 |
|
|
|
|
|
|
Home Loan / Mortgage Loan |
0.000 |
Immovable Properties |
0.000 |
|
|
|
|
|
|
Personal Loan / LIC Loan |
0.000 |
Investments in Shares/ Securities |
0.000 |
|
Car Loan |
0.000 |
Gold/ Jewellery |
2.800 |
|
Any Other Loan/ Liabilities |
0.000 |
Car |
0.000 |
|
|
|
Fixed Deposit / LIC etc. |
0.500 |
|
|
|
Cash in hand |
0.030 |
|
|
|
|
|
|
|
|
Other Investments Capital in Partnership Firm (20% Share) Nava
Sanjivani Drugs 6-3-347/9, Shop No. 1, Dwarkapuri Colony, Punjagutta,
Hyderabad |
5.420 |
|
|
|
|
|
|
|
|
|
|
|
TOTAL [A] |
0.000 |
TOTAL [B] |
8.750 |
|
NETWORTH |
RS.
8.750 MILLION |
------------------------------------------------------------------------------------------------------------------------------
NETWORTH STATEMENT
MR. ANIL KUMAR KANDI
(RS. IN MILLION)
|
LIABILITIES |
31.03.2015 |
ASSETS |
31.03.2015 |
|
|
|
|
|
|
CC Limit with Yes Bank Limited for Prop.
Concern Om Pharma |
23.500 |
Immovable Properties Commercial Shop bearing No. 1, 3-5-1139/ABC
and D, Ground Floor, “Gulab Cyber Avenue”, Ramkote, Hyderabad, admeasuring
2016 Sq. ft. (1/2 Share) |
11.500 |
|
|
|
Commercial Building bearing No. 8-2-255 and
254, Second Bazar, Turner Street, Secunderabad, admeasuring 2450 Sq. ft. |
10.500 |
|
Personal Loan / LIC Loan |
0.000 |
Open Plot bearing No. 50/1, Sanjeevaiahnagar
Coop. House Building Society, Thokatta Village, Bowenpally, Secunderabad
Cant, admeasuring 231 Sq. Yds. |
6.500 |
|
Car Loan |
0.000 |
Open Plot bearing No. 1083, Weavers Colony,
Bhavana Nagar, Kapra, R.R. District, admeasuring 300 Sq. Yds. |
3.000 |
|
Any Other Loan/ Liabilities |
0.000 |
Open Plot bearing No. 49, Silicon Elite,
Block C, Pendyala, Maheshwaram, R. R. District, admeasuring 413 Sq. Yds. (1/2
Share) |
1.200 |
|
|
|
Open Plot bearing No. 47, Silicon Elite,
Block C Pendyala Maheshwaram, R.R. District, admeasuring 606 Sq. Yds. (1/2
Share) |
1.600 |
|
|
|
Residential Flat No. 001, Plot No. 23,
Ground Floor, Four Square More Residency, Gudimalkapur, Hyderabad,
admeasuring 1427 Sq. Ft. |
4.200 |
|
|
|
Agricultural Land bearing Sy. No. 962, 927, 932,
934, 1000, Wargal Village and Mandal, Medak District, admeasuring 6 Acres 38
Guntas (1/4 Share) |
5.000 |
|
|
|
|
|
|
|
|
Investments in Shares/ Securities |
0.250 |
|
|
|
Gold/ Jewellery |
1.000 |
|
|
|
Car |
0.400 |
|
|
|
Fixed Deposit / LIC etc. |
1.200 |
|
|
|
Cash in hand |
0.050 |
|
|
|
|
|
|
|
|
Other Investments Capital in Proprietary Concern. Om Pharma,
8-2-255 and 254, Second Bazar, Turner Street, Seconderabad |
9.500 |
|
|
|
Capital in Partnership Firm (20% Share) Nava
Sanjivani Drugs 6-3-347/9, Shop No. 1 Dwarkapuri Colony, Punjagutta,
Hyderabad |
2.600 |
|
|
|
Capital in Partnership Firm (10% Share).
Fortune Pharmasurge, 2-4-1113/69/A/1 to 3, Kachiguda, Hyderabad |
3.000 |
|
|
|
Capital in Partnership Firm (20% Share). Om
Sree Medisurge Inc, P. No. 126/C, HMT Colony, Kukatpally, Hyderabad |
1.200 |
|
|
|
Capital in Partnership Firm (25% Share). Sri
Sai Medisurge Inc, 1-8-32/27, Bapubagh Colony, P.G. Road, Secunderabad |
0.900 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL [A] |
23.500 |
TOTAL [B] |
63.600 |
|
NETWORTH [Rs. 63.600 Million – Rs. 23.500 Million] |
RS.
40.100 MILLION |
------------------------------------------------------------------------------------------------------------------------------
NETWORTH STATEMENT
MR. NAVEEN KUMAR
PODDATURI
(RS. IN MILLION)
|
LIABILITIES |
31.03.2015 |
ASSETS |
31.03.2015 |
|
|
|
|
|
|
Home Loan / Mortgage Loan |
1.000 |
Immovable Properties Commercial Shop in Padmavathi Tower, Plot
No. 26, Parkview Enclave, Bowenpally, Secunderabad, admeasuring 1500 Sq. ft.
(1/2 Share) |
4.000 |
|
|
|
Residential Building bearing Plot No. 28, HYD
Employees Cooperative Housing Society Colony, Bowenpally, Secunderabad,
admeasuring 315 Sq. Yds. [1/2 Share] |
9.000 |
|
Personal Loan / LIC Loan |
0.000 |
Residential Building bearing Plot No. 18, Sri
Tirumala Cooperative Housing Society, Kakaguda, Secunderabad, admeasuring 153
Sq. Yds. |
15.000 |
|
Car Loan |
0.000 |
Commercial Building bearing Plot No. 164,
Vasavi Nagar, Karkhana, Secunderabad, admeasuring 8000 Sq. ft. (1/2 Share) |
12.500 |
|
Any Other Loan/ Liabilities |
0.000 |
|
|
|
|
|
Investments in Shares/ Securities |
0.000 |
|
|
|
Gold/ Jewellery |
0.500 |
|
|
|
Car |
0.400 |
|
|
|
Fixed Deposit / LIC etc. |
1.200 |
|
|
|
Cash in hand |
0.100 |
|
|
|
|
|
|
|
|
Other Investments Capital in Partnership Firm (20% Share) Nava
Sanjivani Drugs 6-3-347/9, Shop No. 1, Dwarkapuri Colony, Punjagutta,
Hyderabad |
1.000 |
|
|
|
Capital in Partnership Firm (8.33% Share).
Armsburg Basalica, C-6, Vikrampuri, Secunderabad |
2.500 |
|
|
|
Capital in Partnership Firm (8.33% Share).
Arms Constructions, C-6, Vikrampuri, Secunderabad (Debit) |
(1.800) |
|
|
|
Capital in Partnership Firm (25% Share).
Sree Nagarjuna Enterprises, 205, Kabra Complex, MG Road, Secunderabad |
0.250 |
|
|
|
Capital in Partnership Firm (20% Share).
Naveen Finance, 204 and 205, Kabra Complex, MG Road, Secunderabad |
1.800 |
|
|
|
Capital in Partnership Firm (25% Share). Sri
Venkateshwara Enterprises, 204, Kabra Complex, MG Road, Secunderabad |
1.100 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL [A] |
1.000 |
TOTAL [B] |
47.550 |
|
NETWORTH [Rs. 47.550 Million – Rs. 1.000 Million] |
RS.
46.550 MILLION |
------------------------------------------------------------------------------------------------------------------------------
NETWORTH STATEMENT
MR. ARVIND KUMAR KANDI
(RS. IN MILLION)
|
LIABILITIES |
31.03.2015 |
ASSETS |
31.03.2015 |
|
|
|
|
|
|
Home Loan / Mortgage Loan |
0.000 |
Immovable Properties Commercial Shop bearing No. 3-4-181, Tobacco
Bazar, Secunderabad, admeasuring 1500 Sq. ft. |
15.000 |
|
|
|
Open Plot bearing No. 50/2, Sanjeevaiahnagar
Cooperative House Building Society, Thakotta Village, Bowenpally,
Secunderabad Cant, admeasuring 209 Sq. Yds. |
6.000 |
|
Personal Loan / LIC Loan |
0.000 |
Open Plot bearing No. 1040, Weavers Colony, Bhavana
Nagar, Kapra, R.R. District, admeasuring 300 Sq. Yds. |
3.000 |
|
Car Loan |
0.000 |
Open Plot bearing No. 49, Silicon Elite,
Block C, Pendyala, Maheshwaram, R.R. District, admeasuring 413 Sq. Yds [1/2
Share] |
1.200 |
|
Any Other Loan/ Liabilities |
0.000 |
Open Plot bearing No. 47, Silicon Elite,
Block C, Pendyala, Maheshwaram, R.R. District, admeasuring 606 Sq. Yds [1/2
Share] |
1.600 |
|
|
|
|
|
|
|
|
Investments in Shares/ Securities |
0.000 |
|
|
|
Gold/ Jewellery |
0.500 |
|
|
|
Car |
0.000 |
|
|
|
Fixed Deposit / LIC etc. |
1.200 |
|
|
|
Cash in hand |
0.025 |
|
|
|
|
|
|
|
|
Other Investments Capital in Proprietary Concern. Kandi Vishwanatham
and Sons, 3-4-169, Tabacco Bazar, Secunderabad |
3.300 |
|
|
|
Capital in Partnership Firm (20% Share).
Nava Sanjivani Drugs 6-3-347/9, Shop No. 1, Dwarkapuri Colony, Punjagutta,
Hyderabad |
4.000 |
|
|
|
Capital in Partnership Firm (20% Share). Om
Sree Medisurge Inc., P. No. 126/C, HMT Colony Colony, Kukatpally, Hyderabad |
1.900 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL [A] |
0.000 |
TOTAL [B] |
37.725 |
|
NETWORTH |
RS.
37.725 MILLION |
------------------------------------------------------------------------------------------------------------------------------
PROFILE
LOCATION
Subject is strategically located in the lane beside Nizams’ Institute of Medical Sciences and in close vicinity of all major corporates, government and public sector healthcare facilities.
NATURE OF BUSINESS
OPERATION
Subject is a Super Distributor for two companies, in addition to being wholesale distributor for various companies which are into super speciality pharmaceutical business. They ensure on time supplies as per SOP for delivery of high quality medicines with compliance as per companies guidelines for various super speciality products to all major institutes (Government Corporate and Public sector), wholesale dealers, retail chemists and patients directly.
BUSINESS ASSOCIATE
FOR
Roche, Novartis, Sanofi Aventis, Guerbet Fresenius-Kabi, Glenmark, Panacea Biotec, Mylan, Zuventus, Celon Labs and Roche Diagnostics.
TYPE OF BUSINESS
Supply of various speciality products to all major institutes, KIMS, Citizens, Continental, Omega, Indo-American, Star, Rainbow, Sunshine, Century, Care, NIMS, Apollo, Asian Institute of Gastroenterology, Railways, CGHS, APSRTC, SVIMS-Tirupathi, Mahatma Gandhi Cancer Hospital – Vizag and Manipal Hospital – Vijayawada wholesale, retail chemists and patients directly.
OFFICE INFRASTRUCTURE
Subject is equipped with a state of the art office, storage facility and Cold Room with a total space of 1000 Sq. ft., fully equipped to deal with all the SOP requirements of a multinational research based pharmaceutical company.
------------------------------------------------------------------------------------------------------------------------------
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject are
derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 63.19 |
|
|
1 |
Rs. 94.94 |
|
Euro |
1 |
Rs. 67.66 |
INFORMATION DETAILS
|
Information
Gathered by : |
DIP |
|
|
|
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
BVA |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILITY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
48 |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.